The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome

British Journal of Cancer ◽

10.1038/sj.bjc.6603642 ◽

2007 ◽

Vol 96 (7) ◽

pp. 1083-1091 ◽

Author(s):

S R Kumar ◽

R Masood ◽

W A Spannuth ◽

J Singh ◽

J Scehnet ◽

...

Keyword(s):

Ovarian Cancer ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Poor Outcome ◽

Survival Signals

Download Full-text

Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells

Molecular Medicine Reports ◽

10.3892/mmr.2015.3542 ◽

2012 ◽

Vol 12 (1) ◽

pp. 1485-1492 ◽

Author(s):

CHUHEE LEE

Keyword(s):

Ovarian Cancer ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Receptor Tyrosine Kinase ◽

Ovarian Cancer Cells ◽

Taxol Resistance

Download Full-text

A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models

Oncology and Therapy ◽

10.1007/s40487-016-0031-1 ◽

2016 ◽

Vol 4 (2) ◽

pp. 257-274 ◽

Author(s):

Wafaa Hassan ◽

Kenny Chitcholtan ◽

Peter Sykes ◽

Ashley Garrill

Keyword(s):

Ovarian Cancer ◽

Cell Growth ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Ovarian Cancer Cell ◽

Cell Models ◽

Cancer Cell Growth ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

The metastatic role of AXL, a receptor tyrosine kinase, in a genetically engineered mouse model of metastatic, endometrioid ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.139 ◽

2015 ◽

Vol 137 ◽

pp. 60

Author(s):

K.C. Fuh ◽

E.R. Rankin ◽

C.W. Wu ◽

A.D. Diep ◽

A.G. Giaccia

Keyword(s):

Ovarian Cancer ◽

Mouse Model ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Genetically Engineered ◽

Genetically Engineered Mouse Model ◽

Endometrioid Ovarian Cancer

Download Full-text

The in vitro antitumor activity of Siegesbeckia glabrescens against ovarian cancer through suppression of receptor tyrosine kinase expression and the signaling pathways

Oncology Reports ◽

10.3892/or.2013.2468 ◽

2013 ◽

Vol 30 (1) ◽

pp. 221-226 ◽

Author(s):

YOUNG-RAK CHO ◽

SHIN WOOK CHOI ◽

DONG-WAN SEO

Keyword(s):

Ovarian Cancer ◽

Antitumor Activity ◽

Tyrosine Kinase ◽

Signaling Pathways ◽

Receptor Tyrosine Kinase ◽

Kinase Expression

Download Full-text

Abstract LB-149: The OPCML tumor suppressor binds and negatively regulates the Axl receptor tyrosine kinase, sensitizing cells to foretinib in epithelial ovarian cancer (EOC)

10.1158/1538-7445.am2012-lb-149 ◽

2012 ◽

Author(s):

Sushmita Roy Nawathe ◽

Elisa Zanini ◽

Giles Hayward ◽

Arthur B. McKie ◽

Hani Gabra

Keyword(s):

Ovarian Cancer ◽

Tumor Suppressor ◽

Tyrosine Kinase ◽

Epithelial Ovarian Cancer ◽

Receptor Tyrosine Kinase ◽

Axl Receptor Tyrosine Kinase

Download Full-text

Abstract AS19: The role of the receptor tyrosine kinase AXL in an immunocompetent mouse model of invasive endometrioid ovarian cancer

10.1158/1557-3265.ovcasymp14-as19 ◽

2015 ◽

Author(s):

Katherine Fuh ◽

Erinn Rankin ◽

Colleen Wu ◽

Anh Diep ◽

Amato J. Giaccia

Keyword(s):

Ovarian Cancer ◽

Mouse Model ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Immunocompetent Mouse ◽

Endometrioid Ovarian Cancer

Download Full-text

Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian Cancer

International Journal of Molecular Sciences ◽

10.3390/ijms12020971 ◽

2011 ◽

Vol 12 (2) ◽

pp. 971-982 ◽

Author(s):

Jinhua Quan ◽

Tetsuro Yahata ◽

Sosuke Adachi ◽

Kosuke Yoshihara ◽

Kenichi Tanaka

Keyword(s):

Ovarian Cancer ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Serous Ovarian Cancer ◽

Discoidin Domain Receptor ◽

Potential Biomarker ◽

Discoidin Domain Receptor 1

Download Full-text

A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy

Annals of Oncology ◽

10.1093/annonc/mds003 ◽

2012 ◽

Vol 23 (9) ◽

pp. 2265-2271 ◽

Author(s):

K.H. Baumann ◽

A. du Bois ◽

W. Meier ◽

J. Rau ◽

P. Wimberger ◽

...

Keyword(s):

Ovarian Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Phase Ii ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Phase Ii Trial ◽

Multicenter Trial ◽

Dosage Schedule ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-18-0537 ◽

2018 ◽

Vol 18 (2) ◽

pp. 389-398 ◽

Author(s):

Jeanne M. Quinn ◽

Molly M. Greenwade ◽

Marguerite L. Palisoul ◽

Gregory Opara ◽

Katina Massad ◽

...

Keyword(s):

Ovarian Cancer ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase

Download Full-text

Stromal cell expression of the receptor tyrosine kinase DDR2 promotes ovarian cancer metastasis

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.04.043 ◽

2018 ◽

Vol 149 ◽

pp. 17

Author(s):

M. Greenwade ◽

W.R. Grither ◽

A.R. Hagemann ◽

C.K. McCourt ◽

D.G. Mutch ◽

...

Keyword(s):

Ovarian Cancer ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Stromal Cell ◽

Cancer Metastasis ◽

Cell Expression

Download Full-text